Clinical Trial Update: Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia [Phase 2]

View source ↗

Summary

Phase IIa trial update for the oral agent SSS17 in postoperative anemia associated with hip or knee arthroplasty. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Anemia

Drugs mentioned

• SSS17

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Postoperative Anemia, Arthroplasty, Replacement, Hip | Phase 2 | Status: NOT_YET_RECRUITING